![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2021
Wollenberg, A.; Beck, L. A.; Weller, M. Bruin; Simpson, E. L.; Imafuku, S.; Boguniewicz, M.; Zachariae, R.; Olsen, C. K. und Thyssen, J. P.
(2021):
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.
In: British Journal of Dermatology, Bd. 186, Nr. 3: S. 453-465
2020
Reich, K.; DeLozier, A. M.; Nunes, F. P.; Thyssen, J. P.; Eichenfield, L. F.; Wollenberg, A.; Terres, J. A. Ross; Watts, S. D.; Chen, Y-F; Simpson, E. L. und Silverberg, J.
(2020):
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
In: Journal of Dermatological Treatment
Simpson, E. L.; Lacour, J.-P.; Spelman, L.; Galimberti, R.; Eichenfield, L. F.; Bissonnette, R.; King, B. A.; Thyssen, J. P.; Silverberg, J. I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman-Yassky, E.; Beck, L. A.; Janes, J. M.; DeLozier, A. M.; Gamalo, M.; Brinker, D. R.; Cardillo, T.; Nunes, F. P.; Paller, A. S.; Wollenberg, A. und Reich, K.
(2020):
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials.
In: British Journal of Dermatology, Bd. 183, Nr. 2: S. 242-255
Wollenberg, A.; Blauvelt, A.; Guttman-Yassky, E.; Worm, M.; Lynde, C.; Lacour, J.-P.; Spelman, L.; Katoh, N.; Saeki, H.; Poulin, Y.; Lesiak, A.; Kircik, L.; Cho, S. H.; Herranz, P.; Cork, M. J.; Peris, K.; Steffensen, L. A.; Bang, B.; Kuznetsova, A.; Jensen, T. N.; osterdal, M. L. und Simpson, E. L.
(2020):
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
In: British Journal of Dermatology, Bd. 184, Nr. 3: S. 437-449
2019
Wollenberg, A.; Beck, L. A.; Blauvelt, A.; Simpson, E. L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F. A.; Hultsch, T.; Rizova, E.; Rossi, A. B.; Graham, N. M. H.; Pirozzi, G.; Lu, Y. und Ardeleanu, M.
(2019):
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
In: British Journal of Dermatology
Akinlade, B.; Guttman-Yassky, E.; de Bruin-Weller, M.; Simpson, E. L.; Blauvelt, A.; Cork, M. J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J. D.; Mannent, L.; Hamilton, J. D.; Teper, A.; Staudinger, H.; Rizova, E.; Pirozzi, G.; Graham, N. M. H.; Shumel, B.; Ardeleanu, M. und Wollenberg, A.
(2019):
Conjunctivitis in dupilumab clinical trials.
In: British Journal of Dermatology, Bd. 181, Nr. 3: S. 459-473
2017
Simpson, E. L.; Bieber, T.; Guttman-Yassky, E.; Beck, L. A.; Blauvelt, A.; Cork, M. J.; Silverberg, J. I.; Deleuran, M.; Kataoka, Y.; Lacour, J.-P.; Kingo, K.; Worm, M.; Poulin, Y.; Wollenberg, A.; Soo, Y.; Graham, N. M. H.; Pirozzi, G.; Akinlade, B.; Staudinger, H.; Mastey, V.; Eckert, L.; Gadkari, A. und Ardeleanu, M.
(2017):
Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2).
In: Journal Der Deutschen Dermatologischen Gesellschaft, Bd. 15: S. 79
2016
Simpson, E. L.; Bieber, T.; Guttman-Yassky, E.; Beck, L. A.; Blauvelt, A.; Cork, M. J.; Silverberg, J. I.; Deleuran, M.; Kataoka, Y.; Lacour, J.-P.; Kingo, K.; Worm, M.; Poulin, Y.; Wollenberg, A.; Soo, Y.; Graham, N. M. H.; Pirozzi, G.; Akinlade, B.; Staudinger, H.; Mastey, V.; Eckert, L.; Gadkari, A.; Stahl, N.; Yancopoulos, G. D. und Ardeleanu, M.
(2016):
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
In: New England Journal of Medicine, Bd. 375, Nr. 24: S. 2335-2348